Antares Pharma (NASDAQ:ATRS) reported its Q4 earnings results on Thursday, March 3, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
Antares Pharma beat estimated earnings by 100.0%, reporting an EPS of $0.02 versus an estimate of $0.01.
Revenue was up $4.60 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.0 which was followed by a 3.83% increase in the share price the next day.
Here's a look at Antares Pharma's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | 0.03 | 0.01 | 0.01 | 0.03 |
| EPS Actual | 0.03 | 0.03 | 0.02 | 0.03 |
| Revenue Estimate | 48.33M | 42.98M | 38.47M | 40.75M |
| Revenue Actual | 48.19M | 44.98M | 42.08M | 44.13M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
